Cargando…

CBP Bromodomain Inhibition Rescues Mice From Lethal Sepsis Through Blocking HMGB1-Mediated Inflammatory Responses

CREB binding protein (CBP), a transcriptional coactivator and acetyltransferase, is involved in the pathogenesis of inflammation-related diseases. High mobility group box-1 protein (HMGB1) is a critical mediator of lethal sepsis, which has prompted investigation for the development of new treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Xiaowen, Jiang, Baolin, Zhou, Jinyi, Fan, Xirui, Yan, Xintong, Liang, Juanjuan, Luo, Lan, Yin, Zhimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884462/ https://www.ncbi.nlm.nih.gov/pubmed/33603756 http://dx.doi.org/10.3389/fimmu.2020.625542

Ejemplares similares

L-theanine prevents progression of nonalcoholic hepatic steatosis by regulating hepatocyte lipid metabolic pathways via the CaMKKβ-AMPK signaling pathway
por: Liang, Juanjuan, et al.
Publicado: (2022)

A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1
por: Li, Wei, et al.
Publicado: (2007)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
por: Hay, Duncan A., et al.
Publicado: (2014)

Role of HMGB1 in apoptosis-mediated sepsis lethality
por: Qin, Shixin, et al.
Publicado: (2006)

CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs
por: Strachowska, Magdalena, et al.
Publicado: (2021)

Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain
por: Chaikuad, Apirat, et al.
Publicado: (2016)

Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening
por: Zhang, Feng-cai, et al.
Publicado: (2019)

CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation
por: Olzscha, Heidi, et al.
Publicado: (2017)

A small molecule binding HMGB1 inhibits caspase-11-mediated lethality in sepsis
por: Wang, Xiangyu, et al.
Publicado: (2021)

Glycyrrhizin Protects Rats from Sepsis by Blocking HMGB1 Signaling
por: Zhao, Feng, et al.
Publicado: (2017)

Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer
por: Hogg, Simon J., et al.
Publicado: (2022)

Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice
por: Vilmundarson, Ragnar O., et al.
Publicado: (2022)

A Dual-Role of Gu-4 in Suppressing HMGB1 Secretion and Blocking HMGB1 Pro-Inflammatory Activity during Inflammation
por: Zhou, HuiTing, et al.
Publicado: (2014)

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

BET Bromodomain Inhibitors Suppress Inflammatory Activation of Gingival Fibroblasts and Epithelial Cells From Periodontitis Patients
por: Maksylewicz, Anna, et al.
Publicado: (2019)

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Cleavage of HMGB1 by Proteolytic Enzymes Associated with Inflammatory Conditions
por: Sowinska, Agnieszka, et al.
Publicado: (2020)

Prophylactic Treatment With Simvastatin Modulates the Immune Response and Increases Animal Survival Following Lethal Sepsis Infection
por: Braga Filho, Jose A. F., et al.
Publicado: (2018)

Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis
por: An, Andy Y., et al.
Publicado: (2023)

HMGB1 in Systemic Lupus Erythematosus
por: Liu, Tianye, et al.
Publicado: (2020)

Editorial: The Role of HMGB1 in Immunity
por: Son, Myoungsun, et al.
Publicado: (2020)

Targeting Inflammation Driven by HMGB1
por: Yang, Huan, et al.
Publicado: (2020)

The Role of HMGB1 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2022)

Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis
por: Banham, Gemma D., et al.
Publicado: (2022)

Bromodomain-containing Protein 4 regulates innate inflammation via modulation of alternative splicing
por: Mann, Morgan W., et al.
Publicado: (2023)

HMGB1 redox during sepsis
por: Abdulmahdi, Wasan, et al.
Publicado: (2017)

HMGB1: The Central Cytokine for All Lymphoid Cells
por: Li, Guanqiao, et al.
Publicado: (2013)

Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1
por: Gorgulho, Carolina M., et al.
Publicado: (2019)

Review: The role of HMGB1 in spinal cord injury
por: Mo, Yizhang, et al.
Publicado: (2023)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

The Anti-inflammatory Effects of HMGB1 Blockades in a Mouse Model of Cutaneous Vasculitis
por: Wang, Jin, et al.
Publicado: (2020)

Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease
por: Ueno, Kentaro, et al.
Publicado: (2021)

HMGB1 cleavage by complement C1s and its potent anti-inflammatory product
por: Lorvellec, Marie, et al.
Publicado: (2023)

Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis
por: Vicentino, Amanda R. R., et al.
Publicado: (2018)

HMGB1 Promotes the Release of Sonic Hedgehog From Astrocytes
por: Xiao, Yifan, et al.
Publicado: (2021)

Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse
por: Gaboriaud, Christine, et al.
Publicado: (2022)

Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release
por: Sun, Yan, et al.
Publicado: (2018)

BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
por: Zhong, Mengjun, et al.
Publicado: (2022)

Bromodomain inhibitor JQ1 reversibly blocks IFN-γ production
por: Gibbons, Hunter R., et al.
Publicado: (2019)

A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells In Vitro
por: Li, Jianfa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_35j19pbrulqmdmbbpq9rau8lit